Seat has received an order for 26 of its Arona SUVs from the Motor Neurone Disease Association.
The vehicles, in FR 1.0 TSI spec, will be integrated into the charity’s fleet as sole supplier over the coming year.
Reasons for the charity choosing the model are said to include practicality, a competitive total cost of ownership, and a high number of safety features.
Charity staff will use the cars when they visit people with motor neurone disease at homes, hospitals and hospices.
The charity’s facilities manager Phil Day said: “As a charity helping thousands of people affected by motor neurone disease, our fleet of vehicles is crucial and has to be practical, safe and ultimately cost-effective.
“From the get-go, the Seat fleet team was passionate about helping support our fleet, and trying to understand the charity to tailor their offering.
“The Arona FR is a strong proposition already, but that dedication to customer service went above and beyond to seal the deal.”
Seat UK area fleet manager Lindsay Ephgrave said: “We know the quality of the SEAT range – our job is to make sure that we’re understanding our customers so we can tailor our offering to their needs, and our agreement with the Motor Neurone Disease Association is a real sign of how valued that approach is.”